EmbraceRX review

EmbraceRX publishes unusually low starting figures, but the full range is the more useful comparison. A clinician selects the strength, and the product labels do not say that a strength equals one weekly dose. The public information therefore supports a variable-price prescription, not a guaranteed microdose price. Ask which strength, quantity and monthly charge apply to your prescription before relying on the bottom of the range.

Vs median

$94/mo below the $175 median across the 299 of 548 programs here that publish a plain monthly rate

Market

$59–$1,300/mo is the full published spread on this site

Structure

Standard plan, self-directed low dose

Consult

Confirm any separate fee

Dietitian

Not confirmed

Labs

Not stated

Pricing

Check plan terms

EmbraceRX says it uses a 503A pharmacy, but does not say which one. Laboratory requirements are not publicly stated; confirm them with the clinician. Confirm whether clinician visits cost extra.

EmbraceRX offers compounded semaglutide with B12 and compounded tirzepatide through independent clinicians, including Samaritan MD. Each injectable product page prints a monthly price range beside a range of strengths and states that the clinician chooses the appropriate strength after evaluation. Those strength labels are not described as weekly doses, so the lowest price should not be assigned a guessed regimen. The products are prepared through patient-specific 503A pharmacy programs, with no dispensing pharmacy named on the reviewed pages. Alabama is excluded on both injection pages. Oral capsules also appear in the treatment catalog. Payment does not guarantee a prescription, and refund restrictions apply once medication has shipped. The public treatment information does not establish a mandatory laboratory schedule; confirm testing requirements with the clinician.

A listed strength is not established as a weekly dose

• The final price depends on the selected prescription
• The dispensing pharmacy is not named on the product pages

EmbraceRX is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the microdosing evidence shows
• Comparing the complete treatment cost
• Compare treatment costs